apl. Prof. Dr. Stefan Krause

Medizinische Fakultät Department of Medicine 5 – Haematology and Oncology

Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population (2021) Lorch M, Pfirrmann M, Fabisch C, Oberle L, Kohn D, Kohlbrenner K, Bruemmendorf TH, et al. Conference contribution Knowledge transfer to enhance the performance of deep learning models for automated classification of B-cell neoplasms (2021) Mallesh N, Zhao M, Meintker L, Hoellein A, Elsner F, Lueling H, Haferlach T, et al. Conference contribution Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO) (2021) Classen AY, Henze L, Von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, Alakel N, et al. Journal article A surrogate cell-based SARS-CoV-2 spike blocking assay (2021) Schuh W, Baus L, Steinmetz T, Schulz S, Weckwerth L, Roth E, Hauke M, et al. Journal article Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial (2021) Röllig C, Serve H, Noppeney R, Hanoun M, Krug U, Baldus CD, Brandts CH, et al. Journal article The effect of erythrocyte lysing reagents on enumeration of leukocyte subpopulations compared with a no-lyse-no-wash protocol (2021) Plank K, Dorn C, Krause S Journal article Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? (2020) Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Noppeney R, et al. Journal article Nilotinib (NIL) vs. NIL Plus Pegylated Interferon alpha2B (IFN) Induction and NIL or IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1+Chronic Myeloid Leukemia (CML) Patients (PTS) in Chronic Phase (2020) Ernst T, Saussele S, Burchert A, Baerlocher GM, Bruemmendorf TH, La Rosee PG, Heim D, et al. Conference contribution On Its Way to Primetime: Artificial Intelligence in Flow Cytometry Diagnostics (2020) Krause S Journal article